Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.’s Net Profit Rose 31.4% in First Quarter of 2022

Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (浙江我武生物科技股份有限公司) (300357.SZ) reported a net profit of 89 million yuan in the first quarter of 2022, up 31.4% year-on-year.

Meanwhile, the company posted 197.6 million yuan in revenue, up 20% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 86.7 million yuan in total liabilities, with a liability-to-asset ratio of 4.4%.